A COMPARISON OF 5 DEVICES FOR THE BEDSIDE MONITORING OF HEPARIN-THERAPY

被引:30
作者
ONEILL, AI [1 ]
MCALLISTER, C [1 ]
CORKE, CF [1 ]
PARKIN, JD [1 ]
机构
[1] REPATRIAT GEN HOSP,DEPT INTENS CARE,HEIDELBERG,VIC,AUSTRALIA
关键词
INTENSIVE CARE; HEPARIN; ACTIVATED PARTIAL THROMBOPLASTIN TIME; ACTIVATED CLOTTING TIME;
D O I
10.1177/0310057X9101900423
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Five instruments were tested for their capacity to monitor heparin therapy on whole blood at the bedside. The instruments were 512 Coagulation Monitor (Ciba-Corning), Thrombotrack (Nycomed), Automated Coagulation Timer (Hemotec), Hemochron-ACT and Hemochron-APTT (International Technidyne Corporation). Fifty subjects with various levels of heparinisation were tested on each instrument and were also assayed for antithrombin III, fibrinogen, haematocrit, platelet count and plasma heparin level. The results were compared with a reference APTT performed on the Automated Coagulation Laboratory 300R (Instrumentation Laboratories). The Hemochron-ACT correlated least well. The Hemotec and Thrombotrack were unsuitable in a clinical setting because of pipetting requirements, although the Thrombotrack did correlate well with the reference parameters. The The 512 Coagulation Monitor was the simplest to use, but its maximum response corresponded to the midpoint of the reference APTT therapeutic range. The Hemochron-APTT was simple to use, had an adequate response range and correlated well with reference parameters.
引用
收藏
页码:592 / 601
页数:10
相关论文
共 23 条
[1]   COAGULATION-TESTING OF HICKMAN CATHETER BLOOD IN PATIENTS WITH ACUTE-LEUKEMIA [J].
BARTON, JC ;
POON, MC .
ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (11) :2165-2169
[2]   PROSPECTIVE STUDY OF VALUE OF MONITORING HEPARIN TREATMENT WITH ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].
BASU, D ;
CADE, J ;
GALLUS, A ;
HIRSH, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (07) :324-+
[3]   VARIABILITY IN HEPARIN SENSITIVITY OF APTT REAGENTS [J].
BJORNSSON, TD ;
NASH, PV .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 86 (02) :199-204
[4]   GUIDELINES TO CONTROL HEPARIN TREATMENT [J].
FENNERTY, AG ;
RENOWDEN, S ;
SCOLDING, N ;
BENTLEY, DP ;
CAMPBELL, IA ;
ROUTLEDGE, PA .
BMJ-BRITISH MEDICAL JOURNAL, 1986, 292 (6520) :579-580
[5]  
GAWOSKI JM, 1987, ARCH PATHOL LAB MED, V111, P785
[6]   THE EFFECT OF CALCIUM-IONS ON THE ACTIVATED PARTIAL THROMBOPLASTIN TIME OF HEPARINIZED PLASMA [J].
GREENBERG, CS ;
ADAMS, JP ;
MULLEN, PE ;
KOEPKE, JA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 86 (04) :484-489
[7]  
HARBOURNE T, 1987, J CARDIOVASC SURG, V28, P22
[8]  
HOLM HA, 1985, THROMB HAEMOSTASIS, V53, P278
[9]   ROLE OF HEPARIN AFTER INTRAVENOUS THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION [J].
KAPLAN, K ;
DAVISON, R ;
PARKER, M ;
MAYBERRY, B ;
FEIEREISEL, P ;
SALINGER, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (04) :241-244
[10]  
KESHGEGIAN AA, 1986, ARCH PATHOL LAB MED, V110, P520